
September 8, 2017 |
P
ORTLAND, Ore. — Biologist Shoukhrat Mitalipov knew he’d done something pretty big: He’d conducted the first experiment in the U.S. to edit a dysfunctional gene in a viable human embryo. That was sure to spark a debate about designer babies and draw ire from the anti-abortion groups that so vehemently oppose such research.
What Mitalipov didn’t expect, however, was the furious response from fellow researchers — who have aggressively picked apart not the ethics of his work, but…
STAT
Tags: bioethics, crispr, gene-editing, human embryo, shoukrat mitalipov
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.